MEDICATION GUIDE WEGOVY (wee-GOH-vee) (semaglutide) injection, for subcutaneous use Read this Medication Guide and Instructions for Use before you start using WEGOVY and each time you get a refill
Who Is a Good Candidate Semaglutide GLP-1 treatment is suitable for adults with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher with at least one weight-related health condition, such as hypertension or type 2 diabetes
The non-ketogenic moderate low-carbohydrate diet actually increased body weight and perigonadal fat in females
Healthcare providers can help you navigate dose adjustments, manage reduced appetite while meeting essential nutrient requirements, and develop strategies for long-term weight management beyond medication
Retatrutide differs from all dual and mono-agonists through additional activation of the glucagon receptor (GCG-R)
BPC-157 operates through nitric oxide and growth factor pathways while GLP-1 receptor agonists target appetite and insulin signaling, making them mechanistically compatible